Triple

T4069988
Position Surface form Disambiguated ID Type / Status
Subject G. D. Searle & Company E86620 entity
Predicate successor P78 FINISHED
Object Pfizer E108398 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pfizer | Statement: [G. D. Searle & Company, successor, Pfizer]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Pfizer
Context triple: [G. D. Searle & Company, successor, Pfizer]
  • A. Pfizer chosen
    Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
  • B. Merck & Co.
    Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
  • C. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • D. Janssen Pharmaceuticals
    Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
  • E. Roche
    Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69aed93ebe448190a1f1686e28740ac9 completed March 9, 2026, 2:29 p.m.
NER Named-entity recognition batch_69aefbfa45c88190b7b13b35de816378 completed March 9, 2026, 4:57 p.m.
NED1 Entity disambiguation (via context triple) batch_69b562b6eb708190a7f60192d8df9a27 completed March 14, 2026, 1:29 p.m.
Created at: March 9, 2026, 3:38 p.m.